Developer docs
API playgroundTry for free, no card

Search company profiles

Alcaliber

Full company profile

uuid000c2vk

Namestring
Alcaliber
Legal namestring
ALCALIBER, S.A.U.
Websiteurl
alcaliber.com
Company typeenum
Private
Founded yearint
1973
Descriptiontext

Alcaliber, S.A.U. is a privately held Spanish pharmaceutical manufacturer founded in 1973 and headquartered in Madrid, with manufacturing operations in Toledo and Albacete. The company operates a vertically integrated production model spanning poppy cultivation, extraction of narcotic raw materials (NRMs), and manufacturing of Active Pharmaceutical Ingredients (APIs). Its product portfolio centers on alkaloid-based APIs including codeine, morphine, oxycodone, ethylmorphine, pholcodine, dihydrocodeine, diacetylmorphine and noscapine — supplied as Concentrated Poppy Straw (CPS) derivatives or finished APIs — alongside a growing cannabis-derived API and bulk product line authorized since 2016. The company also produces approximately 9,000 tons of poppy seeds annually for the bakery and confectionery industry, and offers CDMO services covering extraction, synthesis (including O-acetylations, hydrogenations, and demethylations), milling, micronization, drying and dosing.

Alcaliber's technical platform is built around proprietary advanced percolation extraction technology (implemented 2014), dual organic solvent and CO2 extraction capabilities, EU-GMP-certified manufacturing areas with a Grade D cleanroom added in 2023, and a purification reactor capacity exceeding 6,000 m³. Operations are regulated under multiple frameworks: Spanish Health Authority licenses for narcotic and cannabis production, EU-GMP Part II-ICH Q7 for alkaloids and cannabinoids, GMP Part I for cannabinoid finished products, FDA certification for agricultural operations, and regular inspections by AEMPS, ANVISA and KDFA. The agricultural network comprises approximately 400 farmers cultivating 6,000-10,000 hectares in Spain annually.

Commercially, Alcaliber operates a B2B direct sales model with quote-based pricing, targeting global pharmaceutical manufacturers requiring controlled-substance APIs and intermediates, as well as food industry buyers for poppy seeds. Distribution is exclusively direct with no public-facing e-commerce. The company is structured as a single-member public limited company (Sociedad Anónima Unipersonal) with a wholly owned R&D subsidiary (Alcaliber Investigación, Desarrollo e Innovación), and is led by a management team with prior tenure at large pharmaceutical companies including MSD, Sanofi, Aventis, and Insud Pharma.

Short descriptiontext

Alcaliber is a privately held Spanish pharmaceutical manufacturer founded in 1973 that operates a vertically integrated model from poppy cultivation to Active Pharmaceutical Ingredient production, supplying alkaloid-based APIs (codeine, morphine, oxycodone), cannabis-derived APIs, and poppy seeds to global pharmaceutical and food industry customers under EU-GMP and FDA certifications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMadrid, Spain
HQ citystring
Madrid
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
active pharmaceutical ingredients, narcotic raw materials, pharmaceutical manufacturing, opium alkaloid production, CDMO pharmaceutical services
Industry1 code
PRIMARYHLAGAHAD
Controlled Substances / DEA-Scheduled API Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code2 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Medicinal and Botanical Manufacturing325411
SIC code3 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
  • Chemicals & Allied Products2800
Product category
Pharmaceutical Manufacturing
Social media profiles1 record
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Alcaliber is a pharmaceutical manufacturer that produces Active Pharmaceutical Ingredients (APIs) and Narcotic Raw Materials (NRMs) from poppy through an integrated chain spanning agricultural cultivation (~6,000–10,000 hectares, ~400 farmers) to finished APIs. Its offerings include CPS Morphine, Codeine, Thebaine, Oripavine and Noscapine, a broad API portfolio (Codeine Phosphate, Morphine Sulphate, Oxycodone, Pholcodine, etc.), pharmaceutical-grade cannabis derivatives, poppy seeds for food, and CDMO solutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 100% supply chain traceability from fields to pharmaceutical products
+3 more records
Product overview1 text field

Alcaliber is a pharmaceutical company with over 50 years of experience cultivating, manufacturing, and marketing alkaloid-based products. The company operates an integrated production model spanning from cultivation to Active Pharmaceutical Ingredients (APIs). Its core product portfolio consists of four main areas: NRMs (Narcotic Raw Materials) including CPS Morphine, Codeine, Thebaine, Oripavine, and Noscapine; APIs such as Codeine Phosphate Hemihydrate, Morphine Sulphate, Oxycodone Hydrochloride, and others; Cannabis products including APIs and pharmaceutical bulk products; and Poppy Seeds for the food industry. Additionally, the company offers CDMO (Contract Development and Manufacturing Organization) services to third parties, providing chemical and physical manufacturing processes.

Product and service5 records
1NRM (Narcotic Raw Materials)
CategoryNarcotic Raw Materials (NRM)
Description

Concentrated Poppy Straw (CPS) Narcotic Raw Materials — CPS Morphine, CPS Codeine, CPS Thebaine, CPS Oripavine and CPS Noscapine — derived from poppy extracts and supplied to pharmaceutical manufacturers of controlled substances.

2Active Pharmaceutical Ingredients (APIs)
CategoryActive Pharmaceutical Ingredients (API)
Description

Portfolio of alkaloid-based APIs including Codeine Phosphate Hemihydrate, Codeine Hydrochloride, Codeine Base, Codeine Camphorsulfonate, Morphine Hydrochloride, Morphine Sulphate, Diacetylmorphine Hydrochloride, Diacetylmorphine Base, Ethylmorphine Hydrochloride, Pholcodine, Dihydrocodeine Hydrogen Tartrate, Oxycodone Hydrochloride and Noscapine, available with ASMF/CEP certification status where applicable.

3Pharmaceutical Cannabis Products
CategoryCannabis pharmaceuticals
Description

Pharmaceutical-grade cannabis products including APIs, extracts, oils and isolated products derived from cannabis for medical use, produced at a dedicated cannabis API production site under EU-GMP.

4Poppy Seeds
CategoryFood ingredients
Description

Poppy seeds for the bakery and confectionery industries, with annual production of approximately 9,000 tons, making Alcaliber one of the world's major producers.

5CDMO Solutions
CategoryContract Development and Manufacturing (CDMO)
Description

Contract Development and Manufacturing Organization services covering extraction to synthesis of new products, including solid-liquid and liquid-liquid extraction, O-acetylations, O-alkylations, demethylations, hydrogenations, milling, micronization, drying, homogenization and dosing, offered to third-party pharmaceutical companies.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Noramco is a global leader in controlled-substance API manufacturing (narcotic raw materials, opiates, stimulants), making it the most direct comparable to Alcaliber's NRM and controlled-substance API business.

TypeDirect peer
Description

Lonza is a leading global CDMO with API manufacturing capabilities, including controlled substances, directly comparable to Alcaliber's CDMO and API business.

TypeDirect peer
Description

Alcami provides API development, manufacturing, and CDMO services for small molecules including controlled substances, comparable to Alcaliber's API and CDMO offerings.

4Tasmanian Alkaloids
TypeDirect peer
Description

Tasmanian Alkaloids (owned by Sun Pharma) cultivates poppies and produces alkaloid APIs, directly comparable to Alcaliber's vertically integrated poppy-to-NRM/API model.

TypeDirect peer
Description

Mallinckrodt operates one of the world's largest poppy-derived alkaloid businesses (via its SpecGx subsidiary) and is a major supplier of controlled-substance APIs, directly comparable to Alcaliber's core business.

TypeDirect peer
Description

Siegfried is a Swiss-headquartered API manufacturer with CDMO services for controlled and non-controlled substances, comparable in scope and customer base to Alcaliber.

TypeBroad incumbent
Description

Sanofi is a major pharmaceutical manufacturer that both produces and consumes APIs (including opiates) and shares customer overlap with Alcaliber's B2B pharma customer base.

8Sun Pharmaceutical Industries
TypeBroad incumbent
Description

Sun Pharma is one of the world's largest generic API manufacturers and owns Tasmanian Alkaloids, making it a broad incumbent with overlapping controlled-substance API exposure.

TypeBroad incumbent
Description

Johnson Matthey's Health division supplies APIs and catalysts to pharmaceutical customers globally; while broader in scope, its API offerings overlap with Alcaliber's controlled-substance and specialty API portfolio.

TypeDirect peer
Description

Cambrex is a pure-play small-molecule API manufacturer offering CDMO and generic API services, comparable to Alcaliber's API manufacturing and CDMO offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Alcaliber

Pharmaceutical Manufacturingalcaliber.com

Alcaliber is a privately held Spanish pharmaceutical manufacturer founded in 1973 that operates a vertically integrated model from poppy cultivation to Active Pharmaceutical Ingredient production, supplying alkaloid-based APIs (codeine, morphine, oxycodone), cannabis-derived APIs, and poppy seeds to global pharmaceutical and food industry customers under EU-GMP and FDA certifications.

What Alcaliber does

Alcaliber, S.A.U. is a privately held Spanish pharmaceutical manufacturer founded in 1973 and headquartered in Madrid, with manufacturing operations in Toledo and Albacete. The company operates a vertically integrated production model spanning poppy cultivation, extraction of narcotic raw materials (NRMs), and manufacturing of Active Pharmaceutical Ingredients (APIs). Its product portfolio centers on alkaloid-based APIs including codeine, morphine, oxycodone, ethylmorphine, pholcodine, dihydrocodeine, diacetylmorphine and noscapine — supplied as Concentrated Poppy Straw (CPS) derivatives or finished APIs — alongside a growing cannabis-derived API and bulk product line authorized since 2016. The company also produces approximately 9,000 tons of poppy seeds annually for the bakery and confectionery industry, and offers CDMO services covering extraction, synthesis (including O-acetylations, hydrogenations, and demethylations), milling, micronization, drying and dosing.

Alcaliber's technical platform is built around proprietary advanced percolation extraction technology (implemented 2014), dual organic solvent and CO2 extraction capabilities, EU-GMP-certified manufacturing areas with a Grade D cleanroom added in 2023, and a purification reactor capacity exceeding 6,000 m³. Operations are regulated under multiple frameworks: Spanish Health Authority licenses for narcotic and cannabis production, EU-GMP Part II-ICH Q7 for alkaloids and cannabinoids, GMP Part I for cannabinoid finished products, FDA certification for agricultural operations, and regular inspections by AEMPS, ANVISA and KDFA. The agricultural network comprises approximately 400 farmers cultivating 6,000-10,000 hectares in Spain annually.

Commercially, Alcaliber operates a B2B direct sales model with quote-based pricing, targeting global pharmaceutical manufacturers requiring controlled-substance APIs and intermediates, as well as food industry buyers for poppy seeds. Distribution is exclusively direct with no public-facing e-commerce. The company is structured as a single-member public limited company (Sociedad Anónima Unipersonal) with a wholly owned R&D subsidiary (Alcaliber Investigación, Desarrollo e Innovación), and is led by a management team with prior tenure at large pharmaceutical companies including MSD, Sanofi, Aventis, and Insud Pharma.

Alcaliber firmographics

Firmographics
Name
Alcaliber
Legal name
ALCALIBER, S.A.U.
Website
https://alcaliber.com
Company type
Private
Founded year
1973
Operating status
Operating
Headcount range
101–250 employees
Short description
Alcaliber is a privately held Spanish pharmaceutical manufacturer founded in 1973 that operates a vertically integrated model from poppy cultivation to Active Pharmaceutical Ingredient production, supplying alkaloid-based APIs (codeine, morphine, oxycodone), cannabis-derived APIs, and poppy seeds to global pharmaceutical and food industry customers under EU-GMP and FDA certifications.
Ownership category
akta.pro rank

Alcaliber industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834), Chemicals & Allied Products (2800)
akta.pro industry
PRIMARYHLAGAHAD
Controlled Substances / DEA-Scheduled API Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Active pharmaceutical ingredients
  • Narcotic raw materials
  • Pharmaceutical manufacturing
  • Opium alkaloid production
  • CDMO pharmaceutical services

Where Alcaliber is headquartered

Location

Headquarters

HQ city
Madrid
HQ country
Spain
HQ region
Europe

Offices3 records

Markets served

Alcaliber business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Distribution channels1 record

Alcaliber product offering

Product offering

Core offering

Alcaliber is a pharmaceutical manufacturer that produces Active Pharmaceutical Ingredients (APIs) and Narcotic Raw Materials (NRMs) from poppy through an integrated chain spanning agricultural cultivation (~6,000–10,000 hectares, ~400 farmers) to finished APIs. Its offerings include CPS Morphine, Codeine, Thebaine, Oripavine and Noscapine, a broad API portfolio (Codeine Phosphate, Morphine Sulphate, Oxycodone, Pholcodine, etc.), pharmaceutical-grade cannabis derivatives, poppy seeds for food, and CDMO solutions.

Product overview

Alcaliber is a pharmaceutical company with over 50 years of experience cultivating, manufacturing, and marketing alkaloid-based products. The company operates an integrated production model spanning from cultivation to Active Pharmaceutical Ingredients (APIs). Its core product portfolio consists of four main areas: NRMs (Narcotic Raw Materials) including CPS Morphine, Codeine, Thebaine, Oripavine, and Noscapine; APIs such as Codeine Phosphate Hemihydrate, Morphine Sulphate, Oxycodone Hydrochloride, and others; Cannabis products including APIs and pharmaceutical bulk products; and Poppy Seeds for the food industry. Additionally, the company offers CDMO (Contract Development and Manufacturing Organization) services to third parties, providing chemical and physical manufacturing processes.

Differentiator

Problem solved

Functional benefit

Products and services

  • NRM (Narcotic Raw Materials) Concentrated Poppy Straw (CPS) Narcotic Raw Materials — CPS Morphine, CPS Codeine, CPS Thebaine, CPS Oripavine and CPS Noscapine — derived from poppy extracts and supplied to pharmaceutical manufacturers of controlled substances.
  • Active Pharmaceutical Ingredients (APIs) Portfolio of alkaloid-based APIs including Codeine Phosphate Hemihydrate, Codeine Hydrochloride, Codeine Base, Codeine Camphorsulfonate, Morphine Hydrochloride, Morphine Sulphate, Diacetylmorphine Hydrochloride, Diacetylmorphine Base, Ethylmorphine Hydrochloride, Pholcodine, Dihydrocodeine Hydrogen Tartrate, Oxycodone Hydrochloride and Noscapine, available with ASMF/CEP certification status where applicable.
  • Pharmaceutical Cannabis Products Pharmaceutical-grade cannabis products including APIs, extracts, oils and isolated products derived from cannabis for medical use, produced at a dedicated cannabis API production site under EU-GMP.
  • Poppy Seeds Poppy seeds for the bakery and confectionery industries, with annual production of approximately 9,000 tons, making Alcaliber one of the world's major producers.
  • CDMO Solutions Contract Development and Manufacturing Organization services covering extraction to synthesis of new products, including solid-liquid and liquid-liquid extraction, O-acetylations, O-alkylations, demethylations, hydrogenations, milling, micronization, drying, homogenization and dosing, offered to third-party pharmaceutical companies.

Quantifiable outcome

  • 100% supply chain traceability from fields to pharmaceutical products
  • +3 more outcomes

Companies that use Alcaliber

Customer profile

Segments3 records

Ideal customer profiles4 records

Alcaliber technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Alcaliber partnerships and signals

Strategic signal

Scale indicators11 records

Recent moves11 records

Expansion highlights5 records

Alcaliber competitors and assessment

Company assessment

Direct peers

  • Noramco: Noramco is a global leader in controlled-substance API manufacturing (narcotic raw materials, opiates, stimulants), making it the most direct comparable to Alcaliber's NRM and controlled-substance API business.
  • Lonza Group: Lonza is a leading global CDMO with API manufacturing capabilities, including controlled substances, directly comparable to Alcaliber's CDMO and API business.
  • Alcami Corporation: Alcami provides API development, manufacturing, and CDMO services for small molecules including controlled substances, comparable to Alcaliber's API and CDMO offerings.
  • Tasmanian Alkaloids: Tasmanian Alkaloids (owned by Sun Pharma) cultivates poppies and produces alkaloid APIs, directly comparable to Alcaliber's vertically integrated poppy-to-NRM/API model.
  • Mallinckrodt Pharmaceuticals: Mallinckrodt operates one of the world's largest poppy-derived alkaloid businesses (via its SpecGx subsidiary) and is a major supplier of controlled-substance APIs, directly comparable to Alcaliber's core business.
  • Siegfried Holding: Siegfried is a Swiss-headquartered API manufacturer with CDMO services for controlled and non-controlled substances, comparable in scope and customer base to Alcaliber.
  • Cambrex: Cambrex is a pure-play small-molecule API manufacturer offering CDMO and generic API services, comparable to Alcaliber's API manufacturing and CDMO offerings.

Broad incumbents

  • Sanofi: Sanofi is a major pharmaceutical manufacturer that both produces and consumes APIs (including opiates) and shares customer overlap with Alcaliber's B2B pharma customer base.
  • Sun Pharmaceutical Industries: Sun Pharma is one of the world's largest generic API manufacturers and owns Tasmanian Alkaloids, making it a broad incumbent with overlapping controlled-substance API exposure.
  • Johnson Matthey: Johnson Matthey's Health division supplies APIs and catalysts to pharmaceutical customers globally; while broader in scope, its API offerings overlap with Alcaliber's controlled-substance and specialty API portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Alcaliber social profiles

Digital presence

Alcaliber compliance and trust

Trust signal

Compliance3 records

Alcaliber financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Alcaliber leadership team

Management profile

Number of profiles

Profiles6 records

Alcaliber subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Alcaliber funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Alcaliber M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alcaliber

What does Alcaliber do?

Alcaliber is a pharmaceutical manufacturer that produces Active Pharmaceutical Ingredients (APIs) and Narcotic Raw Materials (NRMs) from poppy through an integrated chain spanning agricultural cultivation (~6,000–10,000 hectares, ~400 farmers) to finished APIs. Its offerings include CPS Morphine, Codeine, Thebaine, Oripavine and Noscapine, a broad API portfolio (Codeine Phosphate, Morphine Sulphate, Oxycodone, Pholcodine, etc.), pharmaceutical-grade cannabis derivatives, poppy seeds for food, and CDMO solutions.

Is Alcaliber a public or private company?

Alcaliber is a private company. It is classified as private equity controlled and is currently operating.

When was Alcaliber founded?

Alcaliber was founded in 1973. It employs 101 to 250 people.

Where is Alcaliber based?

Alcaliber is headquartered in Madrid, Spain, in the Europe region.

Who are Alcaliber's main competitors?

Direct peers on record are Noramco, Lonza Group, Alcami Corporation, Tasmanian Alkaloids, Mallinckrodt Pharmaceuticals, Siegfried Holding and Cambrex. Broad incumbents are Sanofi, Sun Pharmaceutical Industries and Johnson Matthey.

Does Alcaliber have an API?

No public API is recorded for Alcaliber.

What industry is Alcaliber in?

Alcaliber's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAGAHAD, Controlled Substances / DEA-Scheduled API Manufacturing. Its NAICS code is 3254 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales